Is Pear’s demise a sign of things to come for digital therapeutics?

As Pear Therapeutics’ financial situation forces the company into bankruptcy, Ben Hargreaves takes a look at whether this is just a blip on the road for digital therapeutics, or a sign of darker times to come.